Skip to main content

Table 2 Prognostic value of the NLR in different tumor volume risk groups. Cut-off for the NLR was 4.68

From: Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer

 

3-year recurrence-free survival

3-year overall survival

 

High NLR

Low NLR

Hazard ratio

P value

High NLR

Low NLR

Hazard ratio

P value

Small tumor volume (< 15 cm3)

60%

95%

8.16

0.041

75%

90%

0.95

0.964

Intermediate tumor volume (15–70 cm3)

53%

80%

2.77

0.006

68%

82%

1.95

0.052

High tumor volume (>70 cm3)

28%

74%

5.04

< 0.001

33%

84%

4.16

< 0.001